You are here

Industry News

Advamed Smart Brief

Viveve announces pricing of $20M offering
December 11, 2018
Viveve has priced a follow-on offering of 13.3 million shares at $1.50 apiece in hopes of raising $20 million.  -More- 
Edwards Lifesciences teams with Bay Labs on AI for heart diseases
December 11, 2018
Edwards Lifesciences and Bay Labs have entered a partnership to improve heart disease detection through multiple initiatives, -More- 
Biocept looks to launch stock, warrants offering
December 11, 2018
A prospectus has been filed by Biocept for a public offering of approximately 9.7 millions shares of common stock and warrant -More- 
Fresenius invests in dialysis centers, renal hospitals in China
December 11, 2018
Fresenius Medical Care has made a number of investments in renal hospitals and dialysis centers in China, including the purch -More- 
EarlySense, Hill-Rom enter systems integration deal
December 11, 2018
EarlySense has agreed to integrate its contact-free heart rate and respiratory rate sensing technology into Hill-Rom's Centre -More- 
What is the future of medtech in 2019?
December 11, 2018
2019 promises to be an interesting year!
Cerenovus debuts worldwide registry for blood-clot analysis
December 11, 2018
A global registry has been launched by Cerenovus for the collection and analysis of stroke-inducing blood clots removed using -More- 
Biosensor chip allows less invasive breast cancer diagnosis
December 11, 2018
A team of researchers from the University of Hartford and the University of Connecticut has developed a biosensor chip -- bui -More- 
Hologic's next-gen hysteroscope debuts in US
December 11, 2018
Hologic has announced the US launch of its next-generation Omni hysteroscope after it received 510(k) clearance from the FDA  -More- 
Pear Therapeutics' app wins FDA clearance to help treat opioid abuse
December 11, 2018
Pear Therapeutics has secured clearance from the FDA to market its reSET-O mobile app for use in increasing retention of indi -More- 
Pause

Subscribe to SmartBrief

AdvaMed Top News

AdvaMed Statement on Medical Device Tax Moratorium
Statement | December 10, 2018
Washington, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker as the House Ways and Means Committee released legislation that includes an extension of the moratorium on the medical device tax for an additional 5 years:
Read More
Broad Coalition of Health Care Organizations Urge Repeal of Medical Device Tax
Press Release | December 5, 2018
Washington, D.C. – More than 140 patient advocacy, disability, research, community, and health care industry organizations are calling on Congress to permanently repeal the medical device tax before the end of this year.
Read More
New Study Illustrates Medtech Industry Response to Digital Innovation and Value-based Care Models
Press Release | December 3, 2018
Washington, D.C. – MedTech R&D leaders are adopting a variety of strategies to navigate the changing U.S. health care ecosystem, according to a new study from the Deloitte Center for Health Solutions and the Advanced Medical Technology Association (AdvaMed).
Read More

Industry News

RTI Surgical® to Acquire Paradigm Spine
RTI Surgical®
ALACHUA, Fla., – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction...
Report Outlines Recommendations to Improve Access to NHS Radiotherapy Treatment
Med-Tech Innovation News
The report, from a coalition of stakeholders including leaders from patient groups, academia, government and the private sector, makes several recommendations in an attempt to improve and expand access to advanced radiotherapy services in the UK.
Dthera Sciences Receives FDA Breakthrough Device Designation For Its Alzheimer's Focused Development-Stage Product "DTHR-ALZ"
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.
It’s Time to Reform the Process for Determining What Medicare Covers
Stat News
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and services are covered from region to region needs reform.
CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018
PR Newswire
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...

Twitter Feed

December 11, 2018 - 4:01pm
The medical device tax forces manufacturers to cut staff, scale back important medical research, or go out… https://t.co/ROMPgZOCE3
December 11, 2018 - 3:01pm
This “pacemaker for the brain” uses electrical pulses to identify and stop seizures before they happen. https://t.co/WvJqQgXeV1
December 11, 2018 - 2:30pm
Misleading stories – like many of those included in the investigation – are what really put patients… https://t.co/H8dIqjYFXN
December 11, 2018 - 2:20pm
This innovator is seeking to transform hospital beds into a source of medical data. Get the full story. https://t.co/XP8237jscn
December 11, 2018 - 2:01pm
Learn what’s true and what’s false coming out of the reports. https://t.co/leuLMDsPDH